Cargando…
PROTEOLYTIC ENZYMES : I. THE CONTROL OF THEIR ACTIVITY
1. The literature on conditions affecting the activity of proteolytic enzymes has been reviewed. 2. Experimental data on the control of the activity of trypsin, leucoprotease, papain, serum antiprotease, leucopeptidase, and pancreatic peptidase have been presented. These data indicate that: (a) The...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1946
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2142744/ https://www.ncbi.nlm.nih.gov/pubmed/19873458 |
_version_ | 1782144325476417536 |
---|---|
author | Grob, David |
author_facet | Grob, David |
author_sort | Grob, David |
collection | PubMed |
description | 1. The literature on conditions affecting the activity of proteolytic enzymes has been reviewed. 2. Experimental data on the control of the activity of trypsin, leucoprotease, papain, serum antiprotease, leucopeptidase, and pancreatic peptidase have been presented. These data indicate that: (a) The polymorphonuclearleucocytes of the cat contain abundant proteinase and peptidase active at neutral pH; those of the rabbit lack proteinase active at neutral pH. (b) Reducing agents, including several biologically important thiol-sulfhydryl compounds and ascorbic acid, inhibit the activity of leucoprotease and trypsin. For each reductant the degree of inhibition is proportional to the reducing capacity of the medium. (c) p-Aminobenzoic acid, sulfonamides (especially sulfathiazole), and many diphenyl sulfones inhibit the activity of leucoprotease. (d) Serum, plasma, several heavy metals, ammonium salts, asparagine, thiourea, heparin, glutamic acid, tyrothricin, calcium chloride, and bile salts and bile acids also inhibit the activity of leucoprotease, and in most cases of trypsin too. (e) Preparations of tryptic digests of proteins, and egg white trypsin inhibitor, inhibit trypsin to a much greater degree than leucoprotease. (f) Mild oxidizing agents increase the activity of leucoprotease and trypsin. (g) Oxidizing agents and some inhibitors of sulfhydryl groups inhibit the antiproteolytic activity of the serum. It is suggested that serum antiprotease may consist (chiefly) of reducing agents, including thiol-sulfhydryl peptides which exert their antiproteolytic activity by virtue of the presence of sulfhydryl groups. (h) The antiproteolytic activity of the serum is progressively weakened by exposure to a hydrogen ion concentration below pH 6.5 or above pH 9.7. Because of this the pH optima of leucoprotease and trypsin are shifted in the presence of serum from pH of 7 and 8 to pH of 6 to 6.5, and the range of activity of these enzymes is slightly widened, in both acid and alkaline reactions. (i) Reducing agents increase the activity of leucopeptidase and pancreatic peptidase. Serum, sulfathiazole, and thiourea have little or no effect. 3. The significance of the oxidation-reduction system in the control of the activity of leucoprotease, trypsin, serum antiprotease, leucopeptidase, and pancreatic peptidase has been emphasized. |
format | Text |
id | pubmed-2142744 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1946 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21427442008-04-23 PROTEOLYTIC ENZYMES : I. THE CONTROL OF THEIR ACTIVITY Grob, David J Gen Physiol Article 1. The literature on conditions affecting the activity of proteolytic enzymes has been reviewed. 2. Experimental data on the control of the activity of trypsin, leucoprotease, papain, serum antiprotease, leucopeptidase, and pancreatic peptidase have been presented. These data indicate that: (a) The polymorphonuclearleucocytes of the cat contain abundant proteinase and peptidase active at neutral pH; those of the rabbit lack proteinase active at neutral pH. (b) Reducing agents, including several biologically important thiol-sulfhydryl compounds and ascorbic acid, inhibit the activity of leucoprotease and trypsin. For each reductant the degree of inhibition is proportional to the reducing capacity of the medium. (c) p-Aminobenzoic acid, sulfonamides (especially sulfathiazole), and many diphenyl sulfones inhibit the activity of leucoprotease. (d) Serum, plasma, several heavy metals, ammonium salts, asparagine, thiourea, heparin, glutamic acid, tyrothricin, calcium chloride, and bile salts and bile acids also inhibit the activity of leucoprotease, and in most cases of trypsin too. (e) Preparations of tryptic digests of proteins, and egg white trypsin inhibitor, inhibit trypsin to a much greater degree than leucoprotease. (f) Mild oxidizing agents increase the activity of leucoprotease and trypsin. (g) Oxidizing agents and some inhibitors of sulfhydryl groups inhibit the antiproteolytic activity of the serum. It is suggested that serum antiprotease may consist (chiefly) of reducing agents, including thiol-sulfhydryl peptides which exert their antiproteolytic activity by virtue of the presence of sulfhydryl groups. (h) The antiproteolytic activity of the serum is progressively weakened by exposure to a hydrogen ion concentration below pH 6.5 or above pH 9.7. Because of this the pH optima of leucoprotease and trypsin are shifted in the presence of serum from pH of 7 and 8 to pH of 6 to 6.5, and the range of activity of these enzymes is slightly widened, in both acid and alkaline reactions. (i) Reducing agents increase the activity of leucopeptidase and pancreatic peptidase. Serum, sulfathiazole, and thiourea have little or no effect. 3. The significance of the oxidation-reduction system in the control of the activity of leucoprotease, trypsin, serum antiprotease, leucopeptidase, and pancreatic peptidase has been emphasized. The Rockefeller University Press 1946-03-20 /pmc/articles/PMC2142744/ /pubmed/19873458 Text en Copyright © Copyright, 1946, by The Rockefeller Institute for Medical Research This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Grob, David PROTEOLYTIC ENZYMES : I. THE CONTROL OF THEIR ACTIVITY |
title | PROTEOLYTIC ENZYMES : I. THE CONTROL OF THEIR ACTIVITY |
title_full | PROTEOLYTIC ENZYMES : I. THE CONTROL OF THEIR ACTIVITY |
title_fullStr | PROTEOLYTIC ENZYMES : I. THE CONTROL OF THEIR ACTIVITY |
title_full_unstemmed | PROTEOLYTIC ENZYMES : I. THE CONTROL OF THEIR ACTIVITY |
title_short | PROTEOLYTIC ENZYMES : I. THE CONTROL OF THEIR ACTIVITY |
title_sort | proteolytic enzymes : i. the control of their activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2142744/ https://www.ncbi.nlm.nih.gov/pubmed/19873458 |
work_keys_str_mv | AT grobdavid proteolyticenzymesithecontroloftheiractivity |